In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).
dc.contributor.author | Chirgwin, K | |
dc.contributor.author | Roblin, P M | |
dc.contributor.author | Hammerschlag, M R | |
dc.date.accessioned | 2023-06-07T15:41:55Z | |
dc.date.available | 2023-06-07T15:41:55Z | |
dc.date.issued | 1989-09 | |
dc.identifier.citation | Chirgwin K, Roblin PM, Hammerschlag MR. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR). Antimicrob Agents Chemother. 1989 Sep;33(9):1634-5. doi: 10.1128/AAC.33.9.1634. PMID: 2817862; PMCID: PMC172720. | en_US |
dc.identifier.issn | 0066-4804 | |
dc.identifier.pmid | 2817862 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12648/9908 | |
dc.description.abstract | The in vitro susceptibilities of two clinical isolates of Chlamydia pneumoniae from Brooklyn, N.Y., were determined for tetracycline, erythromycin, sulfamethoxazole, ciprofloxacin, and three new macrolides--azithromycin, clarithromycin, and roxithromycin. Clarithromycin was the most active drug tested, followed by the other macrolides, tetracycline, and ciprofloxacin. | |
dc.language.iso | en | en_US |
dc.relation.url | https://journals.asm.org/doi/10.1128/AAC.33.9.1634 | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR). | en_US |
dc.type | Article/Review | en_US |
dc.source.journaltitle | Antimicrobial agents and chemotherapy | en_US |
dc.source.volume | 33 | |
dc.source.issue | 9 | |
dc.source.beginpage | 1634 | |
dc.source.endpage | 5 | |
dc.source.country | United States | |
dc.description.version | VoR | en_US |
refterms.dateFOA | 2023-06-07T15:41:56Z | |
html.description.abstract | The in vitro susceptibilities of two clinical isolates of Chlamydia pneumoniae from Brooklyn, N.Y., were determined for tetracycline, erythromycin, sulfamethoxazole, ciprofloxacin, and three new macrolides--azithromycin, clarithromycin, and roxithromycin. Clarithromycin was the most active drug tested, followed by the other macrolides, tetracycline, and ciprofloxacin. | |
dc.description.institution | SUNY Downstate | en_US |
dc.description.department | Pediatrics | en_US |
dc.description.degreelevel | N/A | en_US |
dc.identifier.journal | Antimicrobial agents and chemotherapy |